Humana’s Earnings Surge Continues (HUM)
Humana is seeing shares up at new year highs in pre-market trading this morning. The health insurer posted $1.53 EPS versus the $1.48 estimate on revenues of $6.32 Billion versus the $6.22 Billion estimate. …
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 364Most Unusual Analyst Defense of WellCare (WCG)
Late on Thursday, Goldman Sachs has removed WellCare Health Plans (NYSE:WCG) from its Americas Sell List. While this sounds like an upgrade, it is merely a sensible research call. The upgrade from a Sell…
WellCare Braces For Stock Crash (WCG)
WellCare Health Plans, Inc. (NYSE:WCG) has on its website an audio transmission from its Chairman and CEO Todd Farha from Tampa headquarters. Yesterday 24/7 Wall St. noted about how this was going to be…
Align Technology Crooked Teeth (ALGN)
Align Technology Inc. (NASDAQ:ALGN) is getting crushed in after-hours trading. The company posted earnings and announced it was losing a key officer. Total revenues for the third quarter were $71.5 million, a year-over-year increase…
WellCare Shares Punished For FBI Raid (WCG)
Shares of WellCare Health Plans, Inc. (NYSE:WCG) were trading down over an FBI raid at the company’s Tampa, Florida headquarters. Unfortunately there aren’t any details as to what it was about. Obviously it’s not…
Dendreon Sets Stage for 2008 for PROVENGE
Dendreon (NASDAQ:DNDN) has issued a press release noting that it has completed its target enrollment of 500 patients in phase III IMPACT study of PROVENGE for advanced prostate cancer. It also noted: FDA Has…
For Boston Scientific And JNJ, The Stent Stats Get Worse
"William O’Neill, dean of clinical affairs at University of Miami’sMiller School of Medicine, says stent-patient traffic is beginning topick up in South Florida. Still, restoring luster to the popular deviceis likely to be an…
Intuitive Surgical Earnings Stronger Than The Bionic Man (ISRG)
Intuitive Surgical Inc. (NASDAQ:ISRG) saw shares rise a monster 8.3% to $256.44 in active trading ahead of earnings. After the earnings report, it appears shares are trading up another 4.9% in after-hours at $269.00…
Nektar Crushed Under Pfizer’s Boot (NKTR, PFE)
Nektar Therapeutics (NASDAQ:NKTR) is seeing shares hitting 52-week lows after its pharmaceutical partner Pfizer Inc. (NYSE:PFE) unexpectedly said it would end its involvement in inhaled diabetes drug Exubera and return the licensing rights to…
Medarex Hit With Sell Rating (MEDX, BMY)
Medarex (NASDAQ:MEDX) is seeing shares being hit by a research note where Banc of America initiated coverage with a "SELL" rating. This is a fairly thin volume stock in pre-market trading, but shares are…
Cramer’s ‘Improving People’ Picks (ALGN, SNCI)
On tonight’s MAD MONEY on CNBC, Jim Cramer reviewed a couple stocks on what is basically a "bionic you." Obviously that’s a stretch but these are stocks that are medical or quasi medical products…
Boston Scientific (BSX) Tries To Fire Everyone
Will the last one to leave the building please turn out the lights? Boston Scientific (BSX) will apparently ax up to 3,400 people. It appears that CEO James Tobin and his co-founders Peter Michael…
Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)
Shares of Amgen Inc. (NASDAQ:AMGN) are under bit of pressure this morning, although not from any direct news from the company itself. Luckily for Amgen, much of the bad news may already be baked…
Genentech’s Dribble (DNA)
Genentech (NYSE:DNA) posted $0.73 EPS vs $0.72 estimates, but revenues were $2.95 Billion versus a $2.93 Billion estimate. It looks like 3 of the 4 major drugs came in under expectations, with Avastin being…
Genentech To Set Biotech Sector Earnings Bias (DNA)
Genentech Inc. (NYSE:DNA) is set to report earnings after today’s close. First Call has consensus estimates at $0.72 EPS on $2.93 Billion in revenues. The biotech giant usually offers guidance and the next quarter…